Actor & Comedian Kevin Hart and Co-Founder of Gran Coramino James Morrisey discuss the growth of their tequila brand and the highly competitive celebrity-owned tequila space. They talk with Romaine Bostick and Katie Greifeld on "The Close." (Source: Bloomberg)
Actor & Comedian Kevin Hart and Co-Founder of Gran Coramino James Morrisey discuss the growth of their tequila brand and the highly competitive celebrity-owned tequila space. They talk with Romaine Bostick and Katie Greifeld on "The Close." (Source: Bloomberg)
On today’s Big Take podcast, host Sarah Holder and Bloomberg reporter Vernon Silver go inside the world of casino-style games like Monopoly GO! and High 5 Casino to understand who’s profiting the most from their rise and the increased scrutiny on how they do business. (Source: Bloomberg)
On today’s Big Take podcast, host Sarah Holder and Bloomberg reporter Vernon Silver go inside the world of casino-style games like Monopoly GO! and High 5 Casino to understand who’s profiting the most from their rise and the increased scrutiny on how they do business. (Source: Bloomberg)
SINGAPORE, May 01, 2026 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today announced that it received a letter dated April 28, 2026 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notif...
SINGAPORE, May 01, 2026 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today announced that it received a letter dated April 28, 2026 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that since its listed securities did not have a closing bid price of at least US$1.00 for a minimum of 10 consecutive business days during the 180 calendar days ended April 27, 2026, the Company has not regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of US$1.00 per share.
It was the night all the nerves vanished into the ether, replaced by every track on the Leeds United soundtrack as Premier League survival was all but confirmed. It was all too easy to defeat rudderless and relegated Burnley, to put Leeds nine points clear of the relegation zone, with their rivals having four games remaining. Anton Stach’s smart shot started the festivities before Noah Okafor and ...
It was the night all the nerves vanished into the ether, replaced by every track on the Leeds United soundtrack as Premier League survival was all but confirmed. It was all too easy to defeat rudderless and relegated Burnley, to put Leeds nine points clear of the relegation zone, with their rivals having four games remaining. Anton Stach’s smart shot started the festivities before Noah Okafor and Dominic Calvert-Lewin provided the headline act to move Leeds above Newcastle into 14th and extend the gap to 18th-placed Tottenham. The final half an hour at Elland Road was boisterous as the supporters celebrated a crucial victory in what will be a hard-fought journey to safety. Continue reading...
Irvine, California, May 01, 2026 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) filed yesterday with the Securities and Exchange Commission (the “SEC”) its quarterly report on Form 10-Q announcing its financial results for the quarter ended March 31, 2026.
Irvine, California, May 01, 2026 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) filed yesterday with the Securities and Exchange Commission (the “SEC”) its quarterly report on Form 10-Q announcing its financial results for the quarter ended March 31, 2026.
Richard Drury The stock market finished Friday's session modestly higher as Wall Street kicked off the month of May on an optimistic note, with oil prices retreating and corporate earnings going strong. The S&P 500 ( SP500 ) rose 0.3% after closing above the 7.2K level for the first time ever in the prior session, and the tech-heavy Nasdaq Composite ( COMP:IND ) -- crossing the 25K mark for the fi...
Richard Drury The stock market finished Friday's session modestly higher as Wall Street kicked off the month of May on an optimistic note, with oil prices retreating and corporate earnings going strong. The S&P 500 ( SP500 ) rose 0.3% after closing above the 7.2K level for the first time ever in the prior session, and the tech-heavy Nasdaq Composite ( COMP:IND ) -- crossing the 25K mark for the first time—gained 0.9%. Meanwhile, the Dow ( DJI ) edged down 0.3%. Now here are the 3 stocks to watch on Friday after hours—usually a quiet session ahead of the weekend: Cantaloupe ( CTLP ) stock rose 1.6% in after-hours trading after the Federal Trade Commission approved 365 Retail's planned $848M purchase of the company with a required divestiture. Celularity ( CELU ) shares gained 4.5% after disclosing it regained Nasdaq compliance. Universal Logistics ( ULH ) shares dipped 1.4% in extended trading after posting Q1 GAAP EPS of -$0.13 (missing consensus by $0.22) on operating revenue of $367.6M (missing by $4.7M). More on Cantaloupe, Celularity, etc. Universal Logistics: The AI Valuation Paradox Investors Believe Could Trigger A Freight Crisis Celularity regains Nasdaq compliance after delayed filing FTC to allow Cantaloupe sale to 365 Markets with divestiture Seeking Alpha’s Quant Rating on Cantaloupe Historical earnings data for Cantaloupe
The Berkshire Hathaway Annual Shareholders Meeting kicks off in Omaha, NE on May 1, 2026. Yun Li | CNBC OMAHA, Nebraska — At the cavernous exhibit hall inside CHI Health Center Omaha, the annual "Berkshire Bazaar of Bargains" is still stocked with fan-favorite deals, just with a bit more breathing room this year. The 20,000-square-foot shopping event tied to Berkshire Hathaway 's annual meeting fe...
The Berkshire Hathaway Annual Shareholders Meeting kicks off in Omaha, NE on May 1, 2026. Yun Li | CNBC OMAHA, Nebraska — At the cavernous exhibit hall inside CHI Health Center Omaha, the annual "Berkshire Bazaar of Bargains" is still stocked with fan-favorite deals, just with a bit more breathing room this year. The 20,000-square-foot shopping event tied to Berkshire Hathaway 's annual meeting features its usual lineup: Warren Buffett-themed gear from Brooks Sports and chocolate coins from See's Candies, alongside merchandise from dozens of subsidiaries. But unlike past years, lines were shorter and the crowds noticeably thinner. The event came as Buffett, the 95-year-old chairman who has defined the gathering for decades, is no longer expected to headline the marquee Q&A session in the same way, ceding the spotlight to Greg Abel, who took over as CEO at the beginning of 2026. Abel made a point of stopping by every booth in the hall, greeting employees and shaking hands with shareholders. Lines of shareholders formed as he made his way through the hall. Greg Abel, CEO of Berkshire Hathaway, meets with shareholders at the Berkshire Hathaway Annual Shareholders Meeting in Omaha, NE on May 1, 2026. David A. Grogan | CNBC Squishmallows — the plush toy phenomenon owned by Jazwares that Berkshire gained through its 2022 acquisition of Alleghany Corporation — once again pulled in crowds, including for a new Abel-themed plush. Adam Padawer, president of Jazwares, told CNBC that Abel was "engaged, interested and involved," noting the CEO helped design his own Squishmallow. The company also partnered with other Berkshire brands including BNSF Railway, NetJets, GEICO and See's Candies on special-edition versions. Squishmallow display the Berkshire Hathaway Annual Shareholders Meeting in Omaha, NE on May 1, 2026. Sarah Min | CNBC Squishmallows on display at the Berkshire Hathaway Annual Shareholders Meeting in Omaha, NE on May 1, 2026. Yun Li | CNBC Squishmallows on display at...
NAARDEN, the Netherlands and MIAMI, May 01, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficie...
NAARDEN, the Netherlands and MIAMI, May 01, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 50,400 of NewAmsterdam’s ordinary shares to five non-executive new hires. The share options were granted as an inducement material to the employees’ acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).